Phase-specific cancer-immune model considering acquired resistance to therapeutic agents (Q2661016)

From MaRDI portal
Revision as of 21:44, 24 July 2024 by ReferenceBot (talk | contribs) (‎Changed an Item)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
scientific article
Language Label Description Also known as
English
Phase-specific cancer-immune model considering acquired resistance to therapeutic agents
scientific article

    Statements

    Phase-specific cancer-immune model considering acquired resistance to therapeutic agents (English)
    0 references
    0 references
    0 references
    1 April 2021
    0 references
    cancer-immune model
    0 references
    immunotherapy
    0 references
    age-structured model
    0 references
    cancer phase-specific model
    0 references
    resistance to cancer treatment
    0 references
    pharmacokinetics and pharmacodynamics (PKPD)
    0 references
    0 references
    0 references
    0 references

    Identifiers